Skip to main content
SpringerLink
Log in

The critical role of comorbidities and polypharmacy in lower risk myelodysplastic patients: is there any difference between countries?

  • Letter to the Editor
  • Published:
Medical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Castelli R, Schiavon R, Deliliers GL. The impact of anaemia, transfusion dependency, comorbidities and polypharmacy in elderly patients with low-risk myelodysplastic syndromes. Med Oncol. 2018;8;35(3):33. https://doi.org/10.1007/s12032-018-1094-7.

    Article  Google Scholar 

  2. Brunner AM, Blonquist TM, Hobbs GS, Amrein PC, Neuberg DS, Steensma DP, Abel GA, Fathi AT. Risk and timing of cardiovascular death among patients with myelodysplastic syndromes. Blood Adv. 2017;18:2032–40. https://doi.org/10.1182/bloodadvances.2017010165.

    Article  Google Scholar 

  3. Della Porta MG, Malcovati L, Strupp C, Ambaglio I, Kuendgen A, Zipperer E, Travaglino E, Invernizzi R, Pascutto C, Lazzarino M, Germing U, Cazzola M. Risk stratification based on both disease status and extra-hematologic comorbidities in patients with myelodysplastic syndrome. Haematologica. 2011;96(3):441–9. https://doi.org/10.3324/haematol.2010.033506.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cancer Cytogenomic Laboratory, Post-graduate Program in Medical Science, Federal University of Ceara, R. Coronel Nunes de Melo, 1000 - 2° andar - Rodolfo Teófilo, Fortaleza, CE, CEP 60430-275, Brazil

    Priscila da Silva Mendonça, Ronald Pinheiro Feitosa & Silvia Maria Meira Magalhães

Authors
  1. Priscila da Silva Mendonça
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ronald Pinheiro Feitosa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Silvia Maria Meira Magalhães
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Priscila da Silva Mendonça.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mendonça, P.d., Feitosa, R.P. & Magalhães, S.M.M. The critical role of comorbidities and polypharmacy in lower risk myelodysplastic patients: is there any difference between countries?. Med Oncol 35, 143 (2018). https://doi.org/10.1007/s12032-018-1205-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12032-018-1205-5

Search

Navigation